111 related articles for article (PubMed ID: 6449134)
1. Treatment of refractory acute leukemia with aclacinomycin-A.
Takahashi I; Hara M; Adachi T; Takaoka K; Sakano M; Lai M; Kohi F; Yorimitsu S; Tokioka M; Kitajima K; Kimura I; Sanada H
Acta Med Okayama; 1980 Nov; 34(5):349-54. PubMed ID: 6449134
[TBL] [Abstract][Full Text] [Related]
2. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
Warrell RP; Arlin ZA; Kempin SJ; Young CW
Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic results with aclacinomycin A in recurring acute leukemias].
Mitrou PS
Onkologie; 1983 Aug; 6(4):192-4. PubMed ID: 6355949
[TBL] [Abstract][Full Text] [Related]
4. Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemias.
Mitrou PS; Kuse R; Anger H; Herrmann R; Bonfert B; Pralle H; Thiel E; Westerhausen M; Mainzer K; Bartels H
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):919-23. PubMed ID: 3862584
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed acute myelocytic leukemia with a combination of aclarubicin and cytosine arabinoside.
Takahashi I; Hara M; Uchida K; Takaoka K; Watanabe S; Lai M; Hamasaki K; Kohi F; Kitajima K; Kimura I; Adachi T; Yorimitsu S; Tokioka M; Sanada H
Acta Med Okayama; 1982 Feb; 36(1):77-80. PubMed ID: 6950658
[TBL] [Abstract][Full Text] [Related]
6. Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Ribaud P; Schwarzenberg L
Cancer Treat Rep; 1984 Jun; 68(6):881-6. PubMed ID: 6587933
[TBL] [Abstract][Full Text] [Related]
7. Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study.
Dabich L; Bull FE; Beltran G; Athens JW; Coltman CA; Weick JK; Van Slyck EJ; Amare M
Cancer Treat Rep; 1986 Aug; 70(8):967-9. PubMed ID: 3460700
[TBL] [Abstract][Full Text] [Related]
8. Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.
Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Dorval T; Ribaud P
Biomed Pharmacother; 1984; 38(7):328-31. PubMed ID: 6596962
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic trials of aclarubicin in previously treated acute leukemias and hematosarcomas].
Machover D; Goldschmidt E; Benavides M; Gastiaburu J; Vandenbulcke JM; Delgado M; Misset JL; Mathe G
Pathol Biol (Paris); 1987 Jan; 35(1):79-86. PubMed ID: 3550616
[TBL] [Abstract][Full Text] [Related]
10. Aclarubicin in the treatment of elderly patients with acute nonlymphocytic leukemia.
Takahashi I; Yorimitsu S; Hara M; Inagaki T; Nakada H; Sekito N; Hayashi N; Nonaka K; Ohmoto E; Uchida K
Acta Med Okayama; 1986 Jun; 40(3):175-7. PubMed ID: 3461685
[TBL] [Abstract][Full Text] [Related]
11. [Adriamycin-aclacinomycin therapy (AA therapy) for acute leukemia unresponsive to BH-AC-DMP therapy].
Kobayashi M; Tahara T
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1473-9. PubMed ID: 6575727
[TBL] [Abstract][Full Text] [Related]
12. [Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)].
Mathé G; de Jager R; Hulhoven R; Delgado M; Machover D; Ribaud P; de Vassal F; Gil-Delgado M; Misset JL; Gouveia J; Jasmin C; Hayat M; Gastiaburu J; Schwarzenberg L
Nouv Presse Med; 1982 Jan; 11(1):25-8. PubMed ID: 6949137
[TBL] [Abstract][Full Text] [Related]
13. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
Warrell RP
Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
[TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
15. [A case of acute promyelocytic leukemia complicated with severe esophageal stenosis caused by aclacinomycin A].
Kataoka T; Takeyama H; Watanabe E; Yano K
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1686-9. PubMed ID: 3861136
[TBL] [Abstract][Full Text] [Related]
16. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
[TBL] [Abstract][Full Text] [Related]
17. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
[TBL] [Abstract][Full Text] [Related]
18. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
Sampi K; Ogawa M; Kimura I; Ohnoshi T; Yamada K; Masaoka T; Wakui A; Meguro S; Nagai K; Kitani T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3021-7. PubMed ID: 3464230
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of aclarubicin in acute myeloblastic leukemia.
Case DC; Ervin TJ; Boyd MA; Bove LG; Sonneborn HL; Paul SD
Am J Clin Oncol; 1987 Dec; 10(6):523-6. PubMed ID: 3479891
[TBL] [Abstract][Full Text] [Related]
20. Clinical review of aclacinomycin A in Japan.
Ota K
Drugs Exp Clin Res; 1985; 11(1):17-21. PubMed ID: 3869800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]